SCHEMBL8435180

SCHEMBL8435180

COc1ccc2c(c1)C(C(=Cc1ccc(OC)c(OC)c1)C(=O)O)=C(C)C2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.49
▸ MIF P14174 2/20 0.47
▸ CES2 O00748 2/20 0.47
▸ KDM4E B2RXH2 3/20 0.46
▸ HTT P42858 1/20 0.46
▸ AKR1C2 P52895 1/20 0.46
▸ NQO2 P16083 1/20 0.43
▸ ABCG2 Q9UNQ0 2/20 0.42
▸ FLT3 P36888 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ PDE4A P27815 1/20 0.42
▸ PDE4B Q07343 1/20 0.42
▸ PDE4C Q08493 1/20 0.42
▸ PDE4D Q08499 1/20 0.42
▸ ABCB1 P08183 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ TNFRSF1A P19438 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8432678 0.90 MIF (0.46) AKR1C3MIFCES2HTTNQO2
SCHEMBL15572316 0.83 AKR1C3 (0.58) AKR1C3AKR1C2
SCHEMBL15570465 0.82 AKR1C3 (0.39) AKR1C3MIFCES2ABCB1ALDH1A1
SCHEMBL8603397 0.82 AKR1C3 (0.47) AKR1C3MIFCES2
SCHEMBL8430221 0.81 AKR1C3 (0.45) AKR1C3MIFCES2ALDH1A1SMN1; SMN2
SCHEMBL27576965 0.75 ABCG2 (0.62) AKR1C3KDM4EHTTAKR1C2NQO2
SCHEMBL3047082 0.75 AKR1C3 (0.72) AKR1C3KDM4EHTTAKR1C2NQO2
SCHEMBL3047079 0.75 AKR1C3 (0.72) AKR1C3KDM4EHTTAKR1C2NQO2
SCHEMBL11813130 0.74 METAP1 (0.50) MIFCES2KDM4EGAAABCB1
SCHEMBL10603244 0.73 CA2 (0.46) MIFCES2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965619-A ADMINISTERING AN INDENE DERIVATIVE OF GIVEN FORMULA, SUCH AS 1-(2,4,6-TRIMETHOXYBENZYLIDENE)-5-DIMETHYLAMINO-2-METHYL-3-INDENYL ACETIC ACID, TO TREAT PRECANCEROUS LESIONS SUCH AS COLONIC ADENOMATOUS POLYPS; SIDE EFFECT REDUCTION CELL PATHWAYS INC. (US) 1999-10-12 — — US disclosed
US-4656190-A PLATELET ACTIVATING FACTOR MERCK & CO., INC. (US) 1987-04-07 — — US disclosed
Send feedback